Insider · CIK 0001543663

Cvijic Christine Mikail

Reports to the SEC for 4 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001543663

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-07	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−4,200 sh	$36.13	−$152K	84,040
2026-07-06	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−600 sh	$36.02	−$21.6K	88,240
2026-07-02	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−1,530 sh	$35.23	−$53.9K	88,840
2026-07-02	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−2,531 sh	$34.58	−$87.5K	90,370
2026-07-01	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−739 sh	$34.06	−$25.2K	92,901
2026-05-06	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−4,800 sh	$30.07	−$144K	98,440
2026-05-06	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−4,800 sh	$32.44	−$156K	93,640
2026-03-26	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−2,558 sh	$21.62	−$55.3K	103,240
2026-03-13	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−1,395 sh	$21.25	−$29.6K	106,061
2026-03-13	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−263 sh	$22.02	−$5,791.129	105,798
2026-03-13	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−2,387 sh	$20.42	−$48.7K	107,456
2026-02-27	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−4,800 sh	$25.11	−$121K	109,843
2026-02-20	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director, President and CFO	AAward	+132K sh	—	—	131,900
2026-02-20	NGNENeurogene Inc.A Award	Director, President and CFO	AAward	+22K sh	—	—	114,643
2025-03-26	NGNENeurogene Inc. · Employee Stock Option (Right to buy)A Award	Director, President and CFO	AAward	+122K sh	—	—	122,000
2025-03-26	NGNENeurogene Inc.A Award	Director, President and CFO	AAward	+20.3K sh	—	—	92,643
2025-03-13	NGNENeurogene Inc.S Sale	Director, President and CFO	SSale	−4,501 sh	$16.94	−$76.2K	72,343
2024-11-22	NGNENeurogene Inc.P Purchase	Director, President and CFO	PPurchase	+24K sh	$20.48	+$491K	76,844
2024-03-13	NGNENeurogene Inc.A Award	Director, President and CFO	AAward	+31.9K sh	—	—	52,844
2024-03-13	NGNENeurogene Inc. · Employee Stock Option (Right to buy)A Award	Director, President and CFO	AAward	+53.9K sh	—	—	53,900
2016-04-29	Sio Gene Therapies Inc.Employee Stock Option (Right to Buy)A Award	Chief Admin Officer and GC	AAward	+50K sh	—	—	50,000
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP, Legal Affairs & GC	DDisposition to Issuer	−29.1K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCStock Options (right to buy)D Disposition to Issuer	SVP, Legal Affairs & GC	DDisposition to Issuer	−79.5K sh	—	—	0
2015-02-21	NPS PHARMACEUTICALS INCRestricted Stock UnitsD Disposition to Issuer	SVP, Legal Affairs & GC	DDisposition to Issuer	−10.9K sh	—	—	0
2015-02-12	NPS PHARMACEUTICALS INCRestricted Stock UnitsA Award	SVP, Legal Affairs & GC	AAward	+10.9K sh	—	—	10,905
2014-02-10	DENDREON CORPF Tax Payment	EVP, Corp Dev, Gen Cnsl/Scrtry	FTax Payment	−6,167 sh	$2.81	−$17.3K	351,465
2014-02-10	DENDREON CORPA Award	EVP, Corp Dev, Gen Cnsl/Scrtry	AAward	+18K sh	—	—	357,632
2014-01-03	DENDREON CORPA Award	EVP, Corp Dev, Gen Cnsl/Scrtry	AAward	+200K sh	—	—	349,132
2014-01-03	DENDREON CORPF Tax Payment	EVP, Corp Dev, Gen Cnsl/Scrtry	FTax Payment	−9,456 sh	$3.08	−$29.1K	339,676
2013-12-08	DENDREON CORPF Tax Payment	EVP, Corp Dev, Gen Cnsl/Scrtry	FTax Payment	−1,380 sh	$3.01	−$4,153.8	149,132
2013-09-08	DENDREON CORPF Tax Payment	EVP, Corp Dev, Gen Cnsl/Scrtry	FTax Payment	−1,380 sh	$2.88	−$3,974.4	150,512
2013-06-08	DENDREON CORPF Tax Payment	EVP, Corp Dev, Gen Cnsl/Scrtry	FTax Payment	−1,380 sh	$3.90	−$5,382	151,892
2013-03-08	DENDREON CORPF Tax Payment	EVP, Corp Dev, Gen Cnsl/Scrtry	FTax Payment	−5,520 sh	$5.91	−$32.6K	153,272
2013-01-03	DENDREON CORPA Award	EVP, Corp Dev, Gen Cnsl/Scrtry	AAward	+94.5K sh	—	—	158,792
2012-03-08	DENDREON CORPNon-Qualified Stock Option (right to buy)A Award	EVP, Corp Dev, Gen Cnsl/Scrtry	AAward	+129K sh	$10.12	+$1.3M	128,580
2012-03-08	DENDREON CORPA Award	EVP, Corp Dev, Gen Cnsl/Scrtry	AAward	+64.3K sh	—	—	64,290

Recent filings

Accepted (ET)
Jul 74
Cvijic Christine Mikail0001543663-26-000017
SEC(opens sec.gov)
Jul 24
Cvijic Christine Mikail0001543663-26-000015
SEC(opens sec.gov)
May 84
Cvijic Christine Mikail0001543663-26-000013
SEC(opens sec.gov)
Mar 304
Cvijic Christine Mikail0001543663-26-000011
SEC(opens sec.gov)
Mar 174
Cvijic Christine Mikail0001543663-26-000007
SEC(opens sec.gov)
Mar 34
Cvijic Christine Mikail0001543663-26-000005
SEC(opens sec.gov)
Feb 244
Cvijic Christine Mikail0001543663-26-000002
SEC(opens sec.gov)
Mar 284
Cvijic Christine Mikail0001404644-25-000023
SEC(opens sec.gov)
Mar 174
Cvijic Christine Mikail0001404644-25-000007
SEC(opens sec.gov)
Nov 254
Cvijic Christine Mikail0001404644-24-000113
SEC(opens sec.gov)
Mar 144
Cvijic Christine Mikail0001404644-24-000008
SEC(opens sec.gov)

Companies

Address

C/O NEUROGENE INC. 535 W 24TH STREET, 5TH FLOOR

NEW YORK, NY, 10011